Circadian Rhythm Research Antibody Panel

Circadian Target Matrix: Accelerating the R&D Pipeline

1. Core Transcriptional Feedback Loops — The Foundation of Drug Design

Key Targets: BMAL1 (ARNTL), CLOCK, PER1/2/3, CRY1/2

The molecular basis of circadian rhythms is driven by the Transcription-Translation Feedback Loop (TTFL). These proteins constitute the indispensable scaffold for chronobiology research [3].

Drug Discovery Applications:

Mechanism Validation: Establishing the molecular etiology of circadian disruption-related pathologies (e.g., sleep disorders, oncogenesis, and metabolic syndromes).

High-Throughput Screening (HTS): Utilizing core components as primary targets for screening small-molecule circadian modulators.

DMPK Applications:

Regulatory Origin Analysis: Elucidating the fundamental drivers behind the periodic expression of drug-metabolizing enzymes (DMPs) and transporters.

Chronotherapy Guidance: Monitoring the status of the core loop to identify the optimal "dosing window," thereby enhancing the Therapeutic Index (TI).

2. Nuclear Receptor Regulatory Axis — High-Value Druggable Targets

Key Targets: NR1D1 (REV-ERBα), NR1D2 (REV-ERBβ), RORα/β/γ

Nuclear receptors represent the most translational frontier in clock-targeted drug development, bridging the biological clock with metabolism, inflammation, and lipid homeostasis [4].

Drug Discovery Applications:

Metabolic & Inflammatory Pipelines: Core targets for MASH/NAFLD, obesity, and type 2 diabetes.

Pharmacodynamic (PD) Evaluation: Supporting assays for binding affinity and pathway activation kinetics.

DMPK Applications:

Metabolic Network Modulation: Explaining time-of-day variations in drug clearance rates and half-life by assessing liver nuclear receptor networks.

PK/PD Modeling: Providing essential molecular parameters for precision pharmacokinetic modeling.

3. Circadian Output Pathways — Critical Nodes for PK Research

Key Targets: DBP, NFIL3 (E4BP4), HLF, TEF

Circadian signals are executed via Output Pathways that drive downstream effector genes. DBP and NFIL3 are paramount transcription factors regulating the hepatic drug-metabolizing system [5].

Drug Discovery Applications:

Phenotypic Validation: Serving as downstream biomarkers to correlate disease phenotypes with circadian rhythmicity.

DMPK Applications:

ADME Rhythmic Markers: Providing molecular evidence for the diurnal variation in drug absorption and excretion.

Exposure Optimization: Stabilizing drug exposure and reducing inter-individual variability through the study of output factor oscillations.

4. Auxiliary Regulatory Factors — Enhancing Specificity and Depth

Key Targets: Chrono (CIP110), DEC1/2, BHLHE40/41

These factors fine-tune the inhibitory loop, influencing the stability and amplitude of the circadian period.

Drug Discovery Applications:

Model Integrity: Refining protein-complex interaction maps to improve the predictive accuracy of screening models.

Advanced Mechanistic Study: Investigating how aberrant auxiliary factor expression contributes to disease progression.

5. View our full circadian target matrix: Show all »